Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells
1997

Heparin Oligosaccharides as Inhibitors of bFGF Activity

publication Evidence: moderate

Author Information

Author(s): GC Jayson, JT Gallagher

Primary Institution: Cancer Research Campaign Department of Medical Oncology, Paterson Institute

Hypothesis

Can heparin oligosaccharides inhibit the biological activity of basic fibroblast growth factor (bFGF) on Caco-2 cells?

Conclusion

Heparin oligosaccharides, particularly octasaccharides, effectively inhibit the growth and migration responses induced by bFGF in Caco-2 cells.

Supporting Evidence

  • Octasaccharides completely inhibited bFGF-induced growth and migration at a clinically achievable concentration.
  • Intact heparin and larger oligosaccharides did not inhibit bFGF activity.
  • Shorter oligosaccharides were more effective at inhibiting bFGF-induced responses.

Takeaway

This study found that certain small sugar chains can stop cancer cells from growing by blocking a growth factor they need.

Methodology

Caco-2 cells were adapted to serum-free conditions and treated with various lengths of heparin oligosaccharides to assess their effects on bFGF-induced growth and migration.

Limitations

The study primarily focused on a single cell line and may not represent all cancer types.

Participant Demographics

Caco-2 cells, a human colon carcinoma cell line.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication